Medication for myalgic encephalomyelitis / chronic fatigue syndrome

AT529181A2Pending Publication Date: 2026-10-15INSTITUT FÜR LABORWISSENSCHAFTEN DR GREILBERGER GMBH

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: AT2025050213
Authority / Receiving Office: AT · AT
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-03-28
Publication Date: 2026-10-15

Application Information

Patent Timeline

28 Mar 2025

Application

AT2025050213

15 Oct 2026

Publication

AT529181A2

IPC: A61K31/19; A61K31/194; A61K31/215

CPC: A61K31/194; A61K31/19; A61P25/00; A61P43/00; A61K2300/00

Inventors: Joachim Greilberger Dr.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Combination of alpha-ketoglutaric acid or one of its salts or esters and pyruvic acid or a pyruvate as a medicinal product for the treatment of myalgic encephalomyelitis (ME) and / or chronic fatigue syndrome (CFS).

Need to check novelty before this filing date? Find Prior Art